FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to creation and application of aerosol spray compositions for treatment of diseases or disorders requiring lowering of cell proliferation and/or induction of cell apoptosis, such as neoplastic, autoimmune, viral diseases. Agent contains as active substance vitamin E based composition of structural formula 
, where R1 is carboxylic acid; R2 and R3 are hydrogen or R4; R4 is methyl, and R5 is alkyl; or where R1 is hydrogen or carboxylic acid; R2 and R3 are hydrogen or R4; R4 is methyl, and R5 is alkenyl.
EFFECT: improved delivery of specified composition by inhalation with intensified antiproliferation activity.
59 cl, 17 dwg, 6 tbl, 35 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TOCOPHEROLS, TOCOTRIENOLS AND OTHER DERIVATIVES OF CHROMAN AND BY-SIDE CHAINS AND METHODS FOR TREATMENT WITH THEIR USING | 1999 |
|
RU2232758C2 |
| TOCOPHEROLS, TOCOTRIENOLS, OTHER CHROMANS AND DERIVATIVES BY SIDE CHAINS AND THEIR USING | 2001 |
|
RU2263672C2 |
| METHOD FOR IDENTIFYING COMPOUNDS FOR TREATING CANCER | 2010 |
|
RU2575828C2 |
| COMPOSITIONS POSSESSING ANTI-CANCIROGENIC PROPERTIES | 2006 |
|
RU2435580C2 |
| APPLICATION OF MYXOMA VIRUS FOR THERAPEUTIC TREATMENT OF CANCER AND CHRONIC VIRUS INFECTION | 2004 |
|
RU2362584C2 |
| METHOD FOR TREATMENT OF PATIENTS WITH LARGE INTESTINE CANCER OR LUNG CANCER | 2014 |
|
RU2713555C2 |
| THERAPEUTIC USE OF THE TLR AGONIST AND COMBINED THERAPY | 2011 |
|
RU2603467C2 |
| METHOD OF PREVENTION AND/OR TREATMENT OF CANCEROUS DISEASES | 2006 |
|
RU2480201C2 |
| IMMUNE-MODIFYING PARTICLES FOR CANCER TREATMENT | 2019 |
|
RU2794261C2 |
| ANTICANCER COMPOSITION CONTAINING A RECOMBINANT ADENOVIRUS EXPRESSING A DESTRUCTIVE FACTOR FOR AN EXTRACELLULAR MATRIX | 2017 |
|
RU2742726C2 |
